Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

$70 million construction grant

22 Sep 2014 07:00

RNS Number : 1843S
Velocys PLC
22 September 2014
 



22nd September 2014

 

Velocys plc

("Velocys" or "the Company")

 

 $70 million construction grant

 

Velocys plc (VLS.L), the technology innovator for smaller scale gas-to-liquids (GTL), is pleased to announce that its customer, Red Rock Biofuels, has been awarded a $70 million grant to construct a biomass-to-liquids (BTL) plant incorporating Velocys Fischer-Tropsch (FT) technology.

 

Red Rock Biofuels, a Fort Collins, Colorado based subsidiary of IR1 Group LLC ("IR1"), has extensive experience constructing and operating commercial-scale biofuels facilities. This new BTL plant in Oregon will convert some 170,000 tons per year of forestry and sawmill waste into approximately 1,100 barrels per day of ultra clean transportation fuels.

 

The $70 million grant is being awarded under phase 2 of the US Defense Production Act Title III Advanced Drop-in Biofuels project. In July 2013, Red Rock Biofuels was awarded $4.1 million under phase 1 of the same programme to conduct detailed engineering for the BTL facility, which is now complete.

 

Successful execution of Red Rock's project in Oregon is expected to result in revenues to Velocys in excess of $15 million during construction, and an additional $30 million or more over the life of the facility. Red Rock is targeting final investment decision on the project within 6 months, with construction lasting about 18-24 months.

 

Roy Lipski, CEO of Velocys, said:

 

"We are very pleased to see the Red Rock project moving ahead. This $70 million government grant is set to make the Oregon project happen and will act as a catalyst for early adoption of BTL in North America. We are proud to be at the leading edge of this important market."

 

- Ends -

 

For further information, please contact:

 

Velocys

Roy Lipski, CEO

Susan Robertson, CFO

 

 

+1 713 275 5840

+44 1235 841 700

 

Numis Securities (Nomad and Broker)

Alex Ham - Corporate Broking

Stuart Skinner / Jamie Lillywhite - Nominated Adviser

 

+44 20 7260 1000

Camarco (financial communications)

Billy Clegg / Georgia Mann

 

+44 20 3757 4983

Lionsgate Communications (European PR)

Jonathan Charles

 

+44 20 3697 1209

 

Pierpont Communications (North American PR)

Krystal Hewitt

+1 713 627 2223

 

Notes to editors

Velocys enables modular gas-to-liquids (GTL) and biomass-to-liquids (BTL) plants to convert unconventional, remote and problem gas, as well as waste biomass into valuable liquid fuels. Systems based on the Company's technology are significantly smaller than those using conventional technology, enabling modular plants that can be deployed cost effectively at scales that match the biomass collection logistics of BTL facilities. Together with world-class partners, Velocys provides complete modular GTL solutions that address an untapped market of up to 25 million barrels of fuel a day.

 

Velocys plc is listed on the AIM market of the London Stock Exchange (LSE: VLS). The Company has approx. 100 employees with facilities in Houston, Texas, USA and near Oxford, UK and Columbus, Ohio, USA.

 

www.velocys.com

 

About IR1 Group

IR1 Group LLC, is an experienced project developer currently developing next generation biofuels projects. IR1 brings a core set of project development disciplines to guide projects through feasibility, development, finance, design and engineering, construction and operations. In total, to date, IR1 plants represent more than $650 million invested and 325 million gallons of installed capacity.

 

www.ir1group.com

 

About DPA Title III Program

The Defense Production Act Title III Advanced Drop-in Biofuel Production Project ("DPA Title III Program") was established to provide incentives for US operators to create, maintain or expand second generation biofuel production facilities to better meet the needs of the US Department of Defense. The DPA Title III Program is a two phased $420 million initiative, including $210 million in government funding plus matching funds. The first phase awarded up to $5 million to each of four projects to complete detailed engineering, and the second phase awaded grants up to $70 million to help fund construction.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUKVVRSSAKAAR
Date   Source Headline
14th Mar 20237:00 amRNSAppointment of Financial Adviser
13th Mar 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSBusiness Update
25th Jan 202311:07 amRNSVelocys and Bechtel Agreement
6th Jan 20233:06 pmRNSBlock listing Interim Review
12th Dec 20227:01 amRNS£2.5m UK Government grant for new e-fuels project
12th Dec 20227:00 amRNS£27m UK Government grant for Altalto project
27th Oct 20227:00 amRNSVelocys Reference Project Improved Decarbonisation
21st Sep 20227:00 amRNSInterim Results
8th Sep 20227:00 amRNSVelocys to participate in Barclays CEO Conference
1st Sep 20227:00 amRNSTotal Voting Rights
15th Aug 20227:00 amRNSUpdate on climate legislation
28th Jul 20227:00 amRNSAdditional Application for Block Admission
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSBlock listing Interim Review
1st Jul 20227:00 amRNSTotal Voting Rights
23rd Jun 20227:00 amRNSGrant of Share Option to Director
21st Jun 20223:01 pmRNSResults of Annual General Meeting
9th Jun 20227:00 amRNSAppointment of Chief Financial Officer
30th May 20227:00 amRNSMailing of 2021 annual report and AGM notice
23rd May 20224:31 pmRNSHolding(s) in Company
18th May 20224:35 pmRNSPrice Monitoring Extension
17th May 20227:00 amRNSFinal Results
13th May 20229:36 amRNSInvestor Presentation
29th Apr 20227:00 amRNSNotice of Results
19th Apr 20227:00 amRNSFurther business update
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:36 pmRNSPrice Monitoring Extension
4th Apr 20227:00 amRNSBusiness Update and Notice of Results
1st Apr 20223:26 pmRNSNotification of Major Holdings
1st Apr 20223:21 pmRNSNotification of Major Holdings
24th Mar 20227:00 amRNSSale and purchase option agreed for Altalto site
8th Mar 20224:40 pmRNSSecond Price Monitoring Extn
8th Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20221:08 pmRNSHolding(s) in Company
1st Mar 20221:04 pmRNSHolding(s) in Company
1st Mar 202212:25 pmRNSTotal Voting Rights
10th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
5th Jan 20224:30 pmRNSBlock listing Interim Review
23rd Dec 20217:00 amRNSHolding(s) in Company
22nd Dec 20217:00 amRNSHolding(s) in Company
20th Dec 202110:51 amRNSHolding(s) in Company
17th Dec 20218:02 amRNSExercise of Option over Altalto Project Site
17th Dec 20218:01 amRNSDirector/PDMR Dealings
15th Dec 202111:36 amRNSResults of General Meeting and Open Offer
26th Nov 20217:00 amRNSResult of Placing
25th Nov 20215:09 pmRNSProposed Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.